Levy J - Search Results

1

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB, Hunt P, Martin JN, Kahn JO, Levy J, McGrath MS, Hecht FM. Deeks SG, et al. Among authors: levy j. Blood. 2004 Aug 15;104(4):942-7. doi: 10.1182/blood-2003-09-3333. Epub 2004 Apr 29. Blood. 2004. PMID: 15117761 Free article.

2

Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAART.

Martinez-Mariño B, Shiboski S, Hecht FM, Kahn JO, Levy JA. Martinez-Mariño B, et al. AIDS. 2004 Oct 21;18(15):1991-9. doi: 10.1097/00002030-200410210-00003. AIDS. 2004. PMID: 15577620 Clinical Trial.

3

Killian MS, Fujimura SH, Hecht FM, Levy JA. Killian MS, et al. AIDS. 2006 Jun 12;20(9):1247-52. doi: 10.1097/01.aids.0000232231.34253.bd. AIDS. 2006. PMID: 16816552

4

Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individuals.

Castelli JC, Deeks SG, Shiboski S, Levy JA. Castelli JC, et al. Blood. 2002 Jun 1;99(11):4225-7. doi: 10.1182/blood-2001-11-0078. Blood. 2002. PMID: 12010831 Free article.

5

Longitudinal analysis of T-cell receptor gene use by CD8(+) T cells in early human immunodeficiency virus infection in patients receiving highly active antiretroviral therapy.

Schito AM, Vittinghoff E, Hecht FM, Elkins MK, Kahn JO, Levy JA, Oksenberg JR. Schito AM, et al. Among authors: levy ja. Blood. 2001 Jan 1;97(1):214-20. doi: 10.1182/blood.v97.1.214. Blood. 2001. PMID: 11133763 Free article.

6

Use of laboratory tests and clinical symptoms for identification of primary HIV infection.

Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. Hecht FM, et al. Among authors: levy j. AIDS. 2002 May 24;16(8):1119-29. doi: 10.1097/00002030-200205240-00005. AIDS. 2002. PMID: 12004270 Clinical Trial.

7

Potential herpesvirus interaction during HIV type 1 primary infection.

Lennette ET, Busch MP, Hecht FM, Levy JA. Lennette ET, et al. AIDS Res Hum Retroviruses. 2005 Oct;21(10):869-75. doi: 10.1089/aid.2005.21.869. AIDS Res Hum Retroviruses. 2005. PMID: 16225414

8

Variations in plasmacytoid dendritic cell (PDC) and myeloid dendritic cell (MDC) levels in HIV-infected subjects on and off antiretroviral therapy.

Schmidt B, Fujimura SH, Martin JN, Levy JA. Schmidt B, et al. J Clin Immunol. 2006 Jan;26(1):55-64. doi: 10.1007/s10875-006-8401-3. J Clin Immunol. 2006. PMID: 16418803

9

Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.

Hare CB, Pappalardo BL, Busch MP, Karlsson AC, Phelps BH, Alexander SS, Bentsen C, Ramstead CA, Nixon DF, Levy JA, Hecht FM. Hare CB, et al. Clin Infect Dis. 2006 Mar 1;42(5):700-8. doi: 10.1086/500215. Epub 2006 Jan 23. Clin Infect Dis. 2006. PMID: 16447118

10

The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response.

Killian MS, Norris PJ, Rawal BD, Lebedeva M, Hecht FM, Levy JA, Busch MP. Killian MS, et al. Among authors: levy ja. AIDS Res Hum Retroviruses. 2006 Jul;22(7):640-7. doi: 10.1089/aid.2006.22.640. AIDS Res Hum Retroviruses. 2006. PMID: 16831088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,623 results

Search Page

Filters